ShareValue scores for NNG.WAR: Valuation 44, Quality 45, Growth 56, Health 53.
NNG.WARGPW
Nanogroup SA
PLN 2.45
(+5.16%)
NNG.WARGPW
Nanogroup SA
PLN 2.45(+5.16%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
44
Fair Value
Price vs Value
Quality
45
Moderate
Business Strength
Growth
56
Moderate
Revenue & Earnings
Health
53
Moderate
Financial Stability
Momentum
49
Neutral
Price Trend
Company Details
About
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.
Market Cap$104M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1323
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026